| Dommasch E, Gelfand JM Is there truly a risk of lymphoma from biologic therapies? [Journal Article] Dermatol Ther 2009 Sep-Oct; 22(5):418-30. Abstract | Full Citation | Find Related Articles |
| Weinberg JM A sense of insecurity. [Editorial] Cutis 2009 Sep; 84(3):126. Full Citation | Find Related Articles |
| Walling HW, Sontheimer RD Cutaneous lupus erythematosus: issues in diagnosis and treatment. [Journal Article] Am J Clin Dermatol 2009; 10(6):365-81. Abstract | Full Citation |
| Bremmer M, Deng A, Gaspari AA A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 2. [Journal Article] Dermatitis 2009 Oct; 20(5):243-56. Abstract | Full Citation |
| Bremmer M, Deng A, Gaspari AA A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1. [Journal Article] Dermatitis 2009 Aug; 20(4):182-92. Abstract | Full Citation | Find Related Articles |
| Primo J, Michavila J, Jiménez I [Efalizumab-induced autoimmune hepatitis.] [LETTER] Gastroenterol Hepatol 2009 Sep 30. Full Citation | Publisher Full Text | Find Related Articles |
| Guillermo N, Peñate Y, Hernández-Machín B, et al. [Refractory subacute cutaneous lupus erythematosus with a response to efalizumab.] [Journal Article] Actas Dermosifiliogr 2009 Oct; 100(8):734-5. Full Citation | Find Related Articles |
| Immunosuppressants: JC virus encephalopathy. Rare but fatal. [Journal Article] Prescrire Int 2009 Aug; 18(102):168. Full Citation | Find Related Articles |
| Sharma R, Sharma CL, Mahajan A Biological agents targeting beyond TNF-alpha. [Journal Article] Indian J Crit Care Med 2008 Oct; 12(4):181-9. Abstract | Full Citation |
| Major EO Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies. [JOURNAL ARTICLE] Annu Rev Med 2009 Aug 31. Abstract | Full Citation | Find Related Articles |
 |